Mengis Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Mengis Capital Management's VRTX Position: Q3 2026 in Review
Mengis Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 121% in Q3 2026, buying an estimated $317K and bringing the position to 1,131 shares worth $591K. The position accounts for 0.09% of the portfolio, ranked #152.
Mengis Capital Management first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,796 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Mengis Capital Management held 1,131 shares of Vertex Pharmaceuticals worth $591K as of Q3 2026.
- Mengis Capital Management bought 620 Vertex Pharmaceuticals shares in Q3 2026, an estimated $317K.
- Vertex Pharmaceuticals made up 0.09% of Mengis Capital Management's portfolio in Q3 2026, its #152 holding.
- Mengis Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 1,796 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Mengis Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.